Literature DB >> 11337335

Reduction of CSF and blood flow artifacts on FLAIR images of the brain with k-space reordered by inversion time at each slice position (KRISP).

A H Herlihy1, J V Hajnal, W L Curati, N Virji, A Oatridge, B K Puri, G M Bydder.   

Abstract

BACKGROUND AND
PURPOSE: Our purpose was to test a new variant of the fluid-attenuated inversion-recovery (FLAIR) sequence that was designed to reduce CSF and blood flow artifacts by use of a non-slice-selective inversion pulse and k-space reordered by inversion time at each slice position (KRISP).
METHODS: With the KRISP FLAIR sequence, the slice order was cycled so that each inversion time (TI) was associated with a region of k-space rather than a particular slice, and the effective inversion time (TI(eff)) was chosen to null the signal from CSF. Scans were obtained with both conventional and KRISP FLAIR sequences. Studies were performed in 20 adult patients with a variety of brain diseases. Images were evaluated for artifacts from patient motion, CSF, and blood flow, and scored on a four-point scale. The conspicuity of the cortex, meninges, ventricular system, brain stem, and cerebellum was evaluated, as was lesion number and conspicuity.
RESULTS: The KRISP FLAIR sequence showed more patient motion artifacts but had a pronounced advantage over the conventional sequence in control of CSF artifacts around the foramen of Munro, in the third ventricle, aqueduct, and fourth ventricle, as well as in the basal cisterns and around the brain stem and cerebellum. Blood flow artifacts from the internal carotid, basilar, and vertebral arteries were also much better controlled. Spurious high signal in the sylvian branches of the middle cerebral artery was eliminated. The meninges, cortex, ventricular system, brain stem, and cerebellum were better seen due to improved artifact suppression and an edge enhancement effect.
CONCLUSION: The KRISP FLAIR sequence can suppress CSF and blood flow artifacts and improve the conspicuity of the meninges, cortex, brain stem, and cerebellum. Its major disadvantage is its duration, which may be reducible with a fast spin-echo version.

Entities:  

Mesh:

Year:  2001        PMID: 11337335      PMCID: PMC8174936     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  25 in total

1.  Brain lesions: when should fluid-attenuated inversion-recovery sequences be used in MR evaluation?

Authors:  T Okuda; Y Korogi; Y Shigematsu; T Sugahara; T Hirai; I Ikushima; L Liang; M Takahashi
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

2.  Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging.

Authors:  M Essig; M V Knopp; S O Schoenberg; H Hawighorst; F Wenz; J Debus; G van Kaick
Journal:  Radiology       Date:  1999-02       Impact factor: 11.105

3.  MRI diffusion-weighted imaging of the brain: contributions to image contrast from CSF signal reduction, use of a long echo time and diffusion effects.

Authors:  A Oatridge; J V Hajnal; F M Cowan; C J Baudouin; I R Young; G M Bydder
Journal:  Clin Radiol       Date:  1993-02       Impact factor: 2.350

4.  MRI of the brain stem using fluid attenuated inversion recivery pulse sequences.

Authors:  B De Coene; J V Hajnal; J M Pennock; G M Bydder
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

5.  Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.

Authors:  V P Mathews; K S Caldemeyer; M J Lowe; S L Greenspan; D M Weber; J L Ulmer
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

6.  High signal regions in normal white matter shown by heavily T2-weighted CSF nulled IR sequences.

Authors:  J V Hajnal; B De Coene; P D Lewis; C J Baudouin; F M Cowan; J M Pennock; I R Young; G M Bydder
Journal:  J Comput Assist Tomogr       Date:  1992 Jul-Aug       Impact factor: 1.826

7.  Acute subarachnoid hemorrhage: MR imaging with fluid-attenuated inversion recovery pulse sequences.

Authors:  K Noguchi; T Ogawa; A Inugami; H Toyoshima; S Sugawara; J Hatazawa; H Fujita; E Shimosegawa; I Kanno; T Okudera
Journal:  Radiology       Date:  1995-09       Impact factor: 11.105

8.  Subarachnoid space disease: diagnosis with fluid-attenuated inversion-recovery MR imaging and comparison with gadolinium-enhanced spin-echo MR imaging--blinded reader study.

Authors:  M B Singer; S W Atlas; B P Drayer
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

9.  Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence.

Authors:  R H Hashemi; W G Bradley; D Y Chen; J E Jordan; J A Queralt; A E Cheng; J N Henrie
Journal:  Radiology       Date:  1995-08       Impact factor: 11.105

10.  Comparison of fluid-attenuated inversion-recovery MR imaging with CT in a simulated model of acute subarachnoid hemorrhage.

Authors:  K Noguchi; H Seto; Y Kamisaki; G Tomizawa; S Toyoshima; N Watanabe
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

View more
  12 in total

1.  Influence of imaging parameters on high-intensity cerebrospinal fluid artifacts in fast-FLAIR MR imaging.

Authors:  Hsiu-Mei Wu; David M Yousem; Hsiao-Wen Chung; Wan-Yuo Guo; Cheng-Yen Chang; Cheng-Yu Chen
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

2.  The effect of magnetisation transfer contrast on cerebrospinal fluid on motion artefacts on fluid-attenuated inversion-recovery images.

Authors:  I Aprile; M Scapeccia; M Principi; P Ottaviano
Journal:  Neuroradiology       Date:  2003-10-02       Impact factor: 2.804

3.  Comparison of flow artifacts between 2D-FLAIR and 3D-FLAIR sequences at 3 T.

Authors:  Shinji Naganawa; Tokiko Koshikawa; Tatsuya Nakamura; Hisashi Kawai; Hiroshi Fukatsu; Takeo Ishigaki; Tomomi Komada; Katsuya Maruyama; Osamu Takizawa
Journal:  Eur Radiol       Date:  2004-06-19       Impact factor: 5.315

4.  FLAIR diffusion-tensor MR tractography: comparison of fiber tracking with conventional imaging.

Authors:  Ming-Chung Chou; Yi-Ru Lin; Teng-Yi Huang; Chao-Ying Wang; Hsiao-Wen Chung; Chun-Jung Juan; Cheng-Yu Chen
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

5.  Diffusion tensor tractography of the limbic system.

Authors:  Luis Concha; Donald W Gross; Christian Beaulieu
Journal:  AJNR Am J Neuroradiol       Date:  2005-10       Impact factor: 3.825

6.  3D fluid-attenuated inversion recovery imaging: reduced CSF artifacts and enhanced sensitivity and specificity for subarachnoid hemorrhage.

Authors:  N Lummel; V Schoepf; M Burke; H Brueckmann; J Linn
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

7.  Accurate, rapid and reliable, fully automated MRI brainstem segmentation for application in multiple sclerosis and neurodegenerative diseases.

Authors:  Laura Sander; Simon Pezold; Simon Andermatt; Michael Amann; Dominik Meier; Maria J Wendebourg; Tim Sinnecker; Ernst-Wilhelm Radue; Yvonne Naegelin; Cristina Granziera; Ludwig Kappos; Jens Wuerfel; Philippe Cattin; Regina Schlaeger
Journal:  Hum Brain Mapp       Date:  2019-06-17       Impact factor: 5.038

8.  Artifact simulating subarachnoid and intraventricular hemorrhage on single-shot, fast spin-echo fluid-attenuated inversion recovery images caused by head movement: A trap for the unwary.

Authors:  A Cianfoni; M G M Martin; J Du; J R Hesselink; S G Imbesi; W G Bradley; G M Bydder
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

9.  Fluid-attenuated inversion recovery MR imaging and subarachnoid hemorrhage: not a panacea.

Authors:  Mona Mohamed; D Cressler Heasly; Banu Yagmurlu; David M Yousem; D Cressler Heasely
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

Review 10.  Abnormal hyperintensity within the subarachnoid space evaluated by fluid-attenuated inversion-recovery MR imaging: a spectrum of central nervous system diseases.

Authors:  Masayuki Maeda; Akira Yagishita; Tatsuya Yamamoto; Hajime Sakuma; Kan Takeda
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.